CS Extension

Notes

**Note 1**: For skin, patch indicates any size skin lesion without significant elevation or induration. **Note 2**: For skin, plaque indicates any size skin lesion that is elevated or indurated. **Note 3**: For skin, tumor indicates at least one 1 centimeter (cm) diameter solid or nodular lesion with evidence of depth and/or vertical growth. If a physician describes a skin lesion of less than 1 cm as a tumor, use code 550. **Note 4**: Use code 150 when skin involvement is present but only a general location/site is mentioned (i.e., face, torso, arms, legs). Use code 300 when there is skin involvement but there is no mention of location/site. **Note 5**: Ignore erythroderma if stated to involve less than 50% of the skin. Use codes 110-150, 210-230, 300, 550, 600. **Note 6**: Physicians use more than one method to estimate percentage of skin involvement by mycosis fungoides (MF). Code percent of skin involvement as stated by the physician. If no percentage is stated and no word such as localized or generalized is used and no stage is given, code as percent not stated. **Note 7**: Use code 950 ONLY if there is no evidence of any type of skin involvement, including plaques, papules, patches, or tumors. Tumor size is coded as 000 in CS Tumor Size only if there is no evidence of any tumor(s) as defined in the CS Tumor Size table note.
Code Description AJCC 7 T AJCC 6 T Summary Stage 1977 T Summary Stage 2000 T
100 OBSOLETE DATA RETAINED V0200

Plaques, papules, or erythematous patches ("plaque stage"):
Less than 10 % of skin surface, no tumors
Limited plaques/patches
MFCG Stage I
ERROR: T1 L L
110 Patches only with less than 10% of skin surface involved T1a T1 L L
120 Plaques or papules, with or without patches, with less than 10% of skin surface involved, no tumors T1b T1 L L
130 Skin involvement less than 10%, not stated whether plaques, papules or patches, no tumors
Limited plaques/patches
T1NOS T1 L L
150 Plaques, papules, or erythematous patches: % body surface not stated, no tumors T1NOS T1 L L
200 OBSOLETE DATA RETAINED V0200

Plaques, papules, or erythematous patches ("plaque stage"):
Greater than or equal to 10% of skin surface, no tumors
Generalized plaques/patches
MFCG Stage II
ERROR: T2 L L
210 Patches only with 10% or more of skin surface involved T2a T2 L L
220 Plaques or papules, with or without patches, with 10% or more of skin surface involved, no tumors T2b T2 L L
230 Skin involvement 10% or more, not stated whether plaques, papules or patches, no tumors
Generalized plaques/patches

Stated as T2, NOS
T2NOS T2 L L
250 OBSOLETE DATA CONVERTED V0203
See code 150

Plaques, papules, or erythematous patches: % body surface not stated, no tumors
ERROR: ERROR: ERROR: ERROR:
300 Skin involvement, NOS:
Extent not stated, no tumors
Localized, NOS
T1NOS T1 L L
500 OBSOLETE DATA RETAINED V0200

One or more tumors (tumor stage)
Cutaneous tumors
ERROR: T3 RE RE
550 Skin lesion described as tumor less than 1 cm T2NOS T3 RE RE
600 One or more tumors equal to 1 cm or greater
Cutaneous tumor, size not stated
T3 T3 RE RE
650 OBSOLETE DATA CONVERTED V0203
See code 740

Stated as T3 with no other information on extension
ERROR: ERROR: ERROR: ERROR:
700 OBSOLETE DATA RETAINED V0200

Generalized erythroderma (greater than 50% of body involved with diffuse redness)
Sezary syndrome/Sezary disease
MFCG Stage III
ERROR: T4 RE RE
730 Generalized erythroderma
(Greater than 50% less than 80% body surface involved with diffuse redness)
T3 T4 RE RE
740 Stated as T3 with no other information on extension T3 T3 RE RE
750 Generalized erythroderma
(Equal to or greater than or equal to 80% body surface involved with diffuse redness)
T4 T4 RE RE
800 Stated as T4 with no other information on extension T4 T4 RE RE
950 No evidence of primary tumor T0 T0 U U
999 Unknown; extension not stated
Primary tumor cannot be assessed
Not documented in patient record
TX TX U U